Medicine and Dentistry
Encephalitis
100%
Allergic Encephalitis
69%
Patient-Reported Outcome
66%
Immunoassay
47%
Prospective Cohort Study
44%
Gamma-Aminobutyric Acid
42%
Cohort Analysis
40%
Cerebrospinal Fluid
40%
Epileptic Seizure
37%
Central Nervous System Infection
36%
Outcome Assessment
33%
Ganglioglioma
33%
Leucine
33%
Receptor Antibody
33%
NMDA Receptor
33%
Contactin
33%
Recurrent Disease
33%
Systematic Review
33%
Paraneoplastic Cerebellar Degeneration
33%
Cohort Effect
33%
Modified Rankin Scale
33%
Brain Biopsy
33%
Central Nervous System Disease
33%
Diseases
24%
Anti N Methyl D Aspartate Receptor Encephalitis
22%
Social Interaction
22%
Cognitive Defect
22%
Central Nervous System
19%
Inflammatory Disorder
19%
Sequela
17%
Quality of Life
14%
Emotional Well-Being
14%
Glutamate Decarboxylase 65
14%
Disease Course
11%
Final Diagnosis
11%
Receptor
11%
Memory Assessment
11%
Nonparametric Test
11%
Executive Function
11%
Self Report
11%
Disease
9%
Neoplasm
8%
Recurrence Risk
8%
Retrospective Cohort Study
7%
Brain Disease
6%
Health Status
6%
Intracranial Tumor
6%
Biopsy Technique
6%
Tachyarrhythmia
5%
Glasgow Outcome Scale
5%
Pharmacology, Toxicology and Pharmaceutical Science
Encephalitis
66%
4 Aminobutyric Acid
33%
Allergic Encephalitis
33%
Leucine
33%
Recurrent Disease
33%
N Methyl Dextro Aspartic Acid Receptor
33%
Receptor Antibody
33%
Contactin
33%
Diseases
27%
Receptor
19%
Recurrence Risk
14%
Disease Course
11%
Cohort Study
8%
Neoplasm
8%
Health Status
6%
Brain Disease
6%
Immunology and Microbiology
Encephalitis
68%
Cerebrospinal Fluid
42%
Central Nervous System
33%
Anti-NMDA Receptor Encephalitis
33%
Neurofilament
33%
Light Chain
33%
Autoimmune Encephalitis
33%
Inflammatory Disorder
11%
Health Status
6%
